Skip to main content
OpenTrials
Completed

NCT Number: NCT05314543

Power-speed-endurance Profile (Cycling/Rowing) : Optimize Performance of the French Athletes at the Paris Olympics 2024

As part of the preparation at the Paris 2024 Olympic Games, the French rowing and cycling federations and a consortium of researchers met to reach an ultimate goal: to increase the number of medals in these two disciplines for Paris 2024 Olympics.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CEPART, Le Bourget-du-Lac, France

Loading trial locations.

About this study

The objective of this study is to evaluate the maximum capacity of power production of athletes by describing their power-endurance profile and the physiological factors underlying this maximum power generation capacity. These assessments will guide coaches and athletes for:

  • the best use of athletes' physical abilities (for race strategy, cycling gear ratio or rowing levers)
  • adaptation of training program to improve the maximum capacity of power production of the athletes, in order to increase the number of medals at the Paris Olympics 2024.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • experienced, well-trained (national to international level) rowers and cyclists
  • written consent

Exclusion criteria

  • taking medications interfering with measured parameters
  • contraindication to competitive sport practice
  • currently participating in an other structured exercise program
  • muscular, bone or joint injuries
  • neurologic disease
  • pregnant

Treatment and study plan

Hypoxia

Other

Subjects will be subjected to mild hypoxia simulating an altitude of 1750 m (normobaric hypoxia). Hypoxia decreases oxygen supply to tissue and limit exercise capacity. For this, the subjects will inhale a gas mixture depleted in oxygen (enriched in nitrogen). The barometric pressure at 1500 m being 621 mmHg, PIO2 at this altitude (PIO2 = (621 - 47) x 21%) is 120.5 mmHg. For sea level altitude where the barometric pressure is 760 mmHg, the hypoxic gas mixture should contain (x = 120.5 / (760 - 47)) 16.8% O2. Thus, by inhaling a gas mixture that is oxygen-depleted from 21 to 16.8%, subjects (will simulate the altitude of 1750 and) will experience the equivalent of a 20% reduction in oxygen supply.

Primary outcomes

  1. Maximum force produced at zero speed in a fatigue-free condition

    Time frame: Month : 3

    F0i measurement

  2. Speed in a fatigue-free condition

    Time frame: Month : 3

    V0i measurement

  3. Maximum force produced at zero speed at the end of the 3 min.

    Time frame: Month : 3

    F0e measurement

  4. Speed up produced at the end of the 3 min.

    Time frame: Month : 3

    V0e measurement

Secondary outcomes

  1. Maximal oxygen uptake (VO2max)

    Time frame: At inclusion

    Cardiac stress test

  2. Maximal Ventilation (VEmax)

    Time frame: At inclusion

    Cardiac stress test

  3. Cardiac output (QCmax)

    Time frame: At inclusion

    Cardiac stress test

  4. Maximal cardiac frequency (fcmax)

    Time frame: At inclusion

    Cardiac stress test

  5. Fibre type determination

    Time frame: Month : 2

    Muscle biopsy of the vastus lateralis

  6. Microvasculature analysis

    Time frame: Month : 2

    Muscle biopsy of the vastus lateralis

  7. Muscle enzyme activity (Phosphofructokinase (PFK), lactate dehydrogenase (LDH), citrate synthase (CS) et cyclo-oxygenase (COx))

    Time frame: Month : 2

    Muscle biopsy of the vastus lateralis

  8. Maximal voluntary force (N)

    Time frame: Month : 9

    Comparison before and after exercise

  9. Rate of force development

    Time frame: Month : 9

    Comparison of force development

  10. Evoked forces (N)

    Time frame: Month : 9

    Ratio of evoked force at low and high frequencies

  11. Maximum force produced at zero speed in a fatigue-free condition after bicarbonate ingestion

    Time frame: Month : 3

    F0i measurement

  12. Speed in a fatigue-free condition after bicarbonate ingestion

    Time frame: Month : 3

    V0i measurement

  13. Maximum force produced at zero speed at the end of the 3 min after bicarbonate ingestion

    Time frame: Month : 3

    F0e measurement

  14. Speed up produced at the end of the 3 min after bicarbonate ingestion

    Time frame: Month : 3

    V0i measurement

  15. Maximal oxygen uptake (VO2max) after bicarbonate ingestion

    Time frame: At inclusion

    Cardiac stress test

  16. Maximal Ventilation (VEmax) after bicarbonate ingestion

    Time frame: At inclusion

    Cardiac stress test

  17. Cardiac output (QCmax) after bicarbonate ingestion

    Time frame: At inclusion

    Cardiac stress test

  18. Maximal cardiac frequency (fcmax) after bicarbonate ingestion

    Time frame: At inclusion

    Cardiac stress test

  19. Fibre type determination after bicarbonate ingestion

    Time frame: Month : 2

    Muscle biopsy of the vastus lateralis

  20. Microvasculature analysis after bicarbonate ingestion

    Time frame: Month : 2

    Muscle biopsy of the vastus lateralis

  21. Muscle enzyme activity (Phosphofructokinase (PFK), lactate dehydrogenase (LDH), citrate synthase (CS) et cyclo-oxygenase (COx)) after bicarbonate ingestion

    Time frame: Month : 2

    Muscle biopsy of the vastus lateralis

  22. Maximal voluntary force (N) after bicarbonate ingestion

    Time frame: Month : 9

    Comparison before and after exercise

  23. Rate of force development after bicarbonate ingestion

    Time frame: Month : 9

    Comparison of force development

  24. Evoked forces (N) after bicarbonate ingestion

    Time frame: Month : 9

    Ratio of evoked force at low and high frequencies

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Official study title

Description and Determinants of the Power-speed-endurance Profile (PVE) in Cycling and Rowing to Optimize the Performance of the French Athletes at the Paris Olympics 2024

Acronym: THPCA2024

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Apr 6, 2022
Registry last updated
Oct 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.